Enbrel® (etanercept) – Expanded indication
November 4, 2016 – Amgen announced the FDA approval of Enbrel (etanercept) for the treatment of patients 4 years or older with chronic moderate to severe plaque psoriasis (PsO) who are candidates for systemic therapy or phototherapy.
Download PDF
